Eloquent AI | $7,400,000 | (Sep 12, 2025)
Meela Inc. | $3,500,000 | (Sep 12, 2025)
TrustNXT | $1,874,888 | (Sep 12, 2025)
Certified by Founder
Lodge
Dispatch Bio
start up
- 24/07/2025
- Series A
- Undisclosed Amount
Established in 2022, Dispatch Bio was founded with a bold purpose: to help create a world where all cancer patients can be cured. To achieve this, the company is engineering a universal treatment across solid tumors, leveraging its first-in-class Flare platform. This novel approach combines the strengths of immunotherapy with a tumor-specific viral vector, both engineered to clear tumor cells with precision and power. Dispatch has operations in Philadelphia and San Francisco, with access to world-class researchers.
- Industry Biotechnology Research
- Website https://dispatchbio.com/
- LinkedIn https://www.linkedin.com/company/dispatch-bio/
Kriya Therapeutics, Inc. | $320,000,000 | (Sep 12, 2025)
Goodpath | $18,000,000 | (Sep 12, 2025)
BacAlt | $2,037,362 | (Sep 12, 2025)
Quack AI | $7,000,000 | (Sep 12, 2025)
Diana Health (We're Hiring!) | $55,000,000 | (Sep 12, 2025)
OpenHealth Technologies | $3,000,000 | (Sep 12, 2025)
Brain Co. | $30,000,000 | (Sep 12, 2025)
AegisAI Security | $13,000,000 | (Sep 12, 2025)
Clyx | $14,000,000 | (Sep 12, 2025)